Neo Ivy Capital Management purchased a new position in shares of H. B. Fuller Company (NYSE:FUL - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 17,640 shares of the specialty chemicals company's stock, valued at approximately $990,000.
Several other hedge funds have also recently added to or reduced their stakes in the company. Cooke & Bieler LP acquired a new stake in H. B. Fuller during the first quarter worth approximately $36,830,000. Kennedy Capital Management LLC lifted its stake in H. B. Fuller by 13.4% in the fourth quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company's stock valued at $8,630,000 after buying an additional 15,100 shares during the period. MetLife Investment Management LLC grew its position in shares of H. B. Fuller by 4.7% during the 4th quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company's stock worth $2,231,000 after buying an additional 1,472 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in shares of H. B. Fuller during the 4th quarter worth approximately $783,000. Finally, New Age Alpha Advisors LLC bought a new stake in shares of H. B. Fuller in the 4th quarter valued at $465,000. Institutional investors own 95.93% of the company's stock.
Insider Transactions at H. B. Fuller
In other H. B. Fuller news, VP Robert J. Martsching sold 9,546 shares of the firm's stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $64.30, for a total transaction of $613,807.80. Following the transaction, the vice president directly owned 14,980 shares in the company, valued at approximately $963,214. This trade represents a 38.92% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.99% of the company's stock.
H. B. Fuller Stock Down 1.7%
FUL traded down $1.00 during trading on Wednesday, hitting $57.61. 75,958 shares of the company's stock were exchanged, compared to its average volume of 485,456. H. B. Fuller Company has a fifty-two week low of $47.56 and a fifty-two week high of $87.67. The stock has a market cap of $3.11 billion, a P/E ratio of 31.14, a PEG ratio of 0.96 and a beta of 1.12. The business's 50 day moving average is $58.21 and its two-hundred day moving average is $57.34. The company has a quick ratio of 1.15, a current ratio of 1.87 and a debt-to-equity ratio of 1.13.
H. B. Fuller (NYSE:FUL - Get Free Report) last posted its earnings results on Wednesday, June 25th. The specialty chemicals company reported $1.18 earnings per share for the quarter, topping analysts' consensus estimates of $1.10 by $0.08. The company had revenue of $898.10 million for the quarter, compared to analyst estimates of $894.87 million. H. B. Fuller had a net margin of 2.92% and a return on equity of 11.50%. The firm's revenue was down 2.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.12 EPS. As a group, equities analysts expect that H. B. Fuller Company will post 4.07 earnings per share for the current fiscal year.
H. B. Fuller Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, August 14th. Investors of record on Thursday, July 31st will be given a dividend of $0.235 per share. The ex-dividend date is Thursday, July 31st. This represents a $0.94 annualized dividend and a dividend yield of 1.63%. H. B. Fuller's payout ratio is 50.81%.
Analyst Ratings Changes
FUL has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their target price on shares of H. B. Fuller from $50.00 to $54.00 and gave the stock an "underweight" rating in a research note on Friday, June 27th. Robert W. Baird upped their price objective on shares of H. B. Fuller from $60.00 to $75.00 and gave the company an "outperform" rating in a report on Friday, June 27th. Finally, Baird R W upgraded H. B. Fuller from a "hold" rating to a "strong-buy" rating in a research note on Thursday, April 17th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $67.25.
Get Our Latest Stock Report on H. B. Fuller
H. B. Fuller Company Profile
(
Free Report)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Further Reading

Before you consider H. B. Fuller, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H. B. Fuller wasn't on the list.
While H. B. Fuller currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.